1. Home
  2. TRDA vs SY Comparison

TRDA vs SY Comparison

Compare TRDA & SY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

TRDA

Entrada Therapeutics Inc.

N/A

Current Price

$4.39

Market Cap

275.3M

Sector

Health Care

ML Signal

N/A

Logo So-Young International Inc. American Depository Shares

SY

So-Young International Inc. American Depository Shares

SELL

Current Price

$1.67

Market Cap

195.2M

Sector

Technology

ML Signal

SELL

Company Overview

Basic Information
Metric
TRDA
SY
Founded
2016
2013
Country
United States
China
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
EDP Services
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
275.3M
195.2M
IPO Year
2021
2018

Fundamental Metrics

Financial Performance
Metric
TRDA
SY
Price
$4.39
$1.67
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
8
2
Target Price
★ $17.75
$7.34
AVG Volume (30 Days)
★ 474.8K
228.5K
Earning Date
11-05-2026
12-02-2026
Dividend Yield
N/A
★ 1.41%
EPS Growth
N/A
★ N/A
EPS
N/A
★ N/A
Revenue
★ $25,421,000.00
N/A
Revenue This Year
N/A
$34.60
Revenue Next Year
$161.27
$36.03
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$4.11
$1.28
52 Week High
$16.45
$3.90

Technical Indicators

Market Signals
Indicator
TRDA
SY
Relative Strength Index (RSI) 40.77 28.12
Support Level $4.18 $1.28
Resistance Level $5.13 $1.79
Average True Range (ATR) 0.48 0.14
MACD 0.01 -0.01
Stochastic Oscillator 7.14 3.69

Price Performance

Historical Comparison
TRDA
SY

About TRDA Entrada Therapeutics Inc.

Entrada Therapeutics Inc is a clinical-stage biopharmaceutical company. It aims to transform the lives of patients by establishing a new class of medicines that engage intracellular targets that have long been considered inaccessible. The company's Endosomal Escape Vehicle (EEV)-therapeutics are designed to enable the efficient intracellular delivery into a variety of organs and tissues, resulting in an improved therapeutic index and protein-based programs for the potential treatment of neuromuscular and ocular diseases, among others. Its oligonucleotide programs are in development for the potential treatment of people living with Duchenne, which are exon 44, 45, 50, and 51 skipping amenable. It has partnered to develop a clinical-stage program, VX-670, for myotonic dystrophy type 1.

About SY So-Young International Inc. American Depository Shares

So-Young International Inc is an aesthetic treatment platform in China connecting consumers with online services and offline treatments. Its online platform operates across multiple access points, including mobile app, Weixin mini program, and soyoung.com website, where both consumers and aesthetic practitioners can access media content, an engaging social community and a transparent reservation system. The company has four reportable segments: Aesthetic treatment services group, Platform service group, Wuhan Miracle, and Others. The majority of revenue is derived from the Platform service group, which generates revenue by providing information services and reservation services. All the company's revenues are derived from within the PRC.

Share on Social Networks: